Found: 21
Select item for more details and to access through your institution.
Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 2, p. 449, doi. 10.1002/ijc.21347
- By:
- Publication type:
- Article
Differential Expression of Cysteinyl Leukotriene Receptor 1 and 15-Lipoxygenase-1 in Non-Hodgkin Lymphomas.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 6, p. 340
- By:
- Publication type:
- Article
Human 15-lipoxygenase-1 is a regulator of dendritic-cell spreading and podosome formation.
- Published in:
- FASEB Journal, 2017, v. 31, n. 2, p. 491, doi. 10.1096/fj.201600679RR
- By:
- Publication type:
- Article
Hodgkin Lymphoma Monozygotic Triplets Reveal Divergences in DNA Methylation Signatures.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.598872
- By:
- Publication type:
- Article
Activation of Telomerase by Human Cytomegalovirus.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 7, p. 488, doi. 10.1093/jnci/djp031
- By:
- Publication type:
- Article
Expression of the signal transduction molecule ζ in peripheral and tumour-associated lymphocytes in Hodgkin's disease in relation to the Epstein–Barr virus status of the tumour cells.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 4, p. 765, doi. 10.1046/j.0007-1048.2002.03342.x
- By:
- Publication type:
- Article
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- Oncologist, 2018, v. 23, n. 5, p. 631, doi. 10.1634/theoncologist.2017-0301
- By:
- Publication type:
- Article
The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non-Hodgkin's B-Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for...
- Published in:
- Oncologist, 2013, v. 18, n. 5, p. 625, doi. 10.1634/theoncologist.2013-0020
- By:
- Publication type:
- Article
Splenectomised Hodgkin lymphoma patients: does severe pneumococcal disease pose a problem today and what is the best long-term strategy?
- Published in:
- 2023
- By:
- Publication type:
- Letter
The expression of cytosolic phospholipase A<sub>2</sub> and biosynthesis of leukotriene B<sub>4</sub> in acute myeloid leukemia cells.
- Published in:
- European Journal of Haematology, 2007, v. 79, n. 6, p. 468, doi. 10.1111/j.1600-0609.2007.00967.x
- By:
- Publication type:
- Article
Setae from Larvae of the Northern Processionary Moth (Thaumetopoea pinivora, TP) Stimulate Proliferation of Human Blood Lymphocytes In Vitro.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0113977
- By:
- Publication type:
- Article
Interleukin-4-Mediated 15-Lipoxygenase-1 Trans-Activation Requires UTX Recruitment and H3K27me3 Demethylation at the Promoter in A549 Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0085085
- By:
- Publication type:
- Article
Transcriptional Regulation of 15-Lipoxygenase Expression by Histone H3 Lysine 4 Methylation/ Demethylation.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052703
- By:
- Publication type:
- Article
Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Multidrug resistance in relapsed acute myeloid leukemia: Evidence of biological heterogeneity Multidrug resistance in relapsed acute myeloid leukemia: Evidence of biological heterogeneity.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 16, p. 3076, doi. 10.1002/cncr.28098
- By:
- Publication type:
- Article
Hodgkin Reed–Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo.
- Published in:
- FEBS Journal, 2008, v. 275, n. 16, p. 4222, doi. 10.1111/j.1742-4658.2008.06570.x
- By:
- Publication type:
- Article
Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case-control study from Sweden.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 6, p. 563, doi. 10.1007/s12185-015-1772-6
- By:
- Publication type:
- Article
Tumour necrosis factor-α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 1999, v. 104, n. 2, p. 346, doi. 10.1046/j.1365-2141.1999.01176.x
- By:
- Publication type:
- Article
Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease.
- Published in:
- British Journal of Haematology, 1996, v. 92, n. 2, p. 393, doi. 10.1046/j.1365-2141.1996.00358.x
- By:
- Publication type:
- Article
Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 10, p. 2285, doi. 10.1002/ijc.23781
- By:
- Publication type:
- Article